Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated just now
Peer-reviewedCC BYAntibiotics (Basel, Switzerland)

Genomic Insight into Escherichia coli Bloodstream Infections at a Tertiary Hospital in Shanghai: Predominance, Genetic Diversity, and Plasmid-Associated Virulence of CC131 and CC14.

  1. 1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  2. 2Department of Clinical Laboratory, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
  3. 3Department of Laboratory Medicine, Taicang Loujiang New City Hospital (Taicang Branch of Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine), Taicang 215400, China.

Abstract

Background: Bloodstream infection (BSI) caused by Escherichia coli has become a growing clinical threat due to its high incidence and mortality rates. Despite its significant global health burden, the genomic diversity of E. coli in Shanghai has not been systematically investigated, with ramifications for treatment and prevention. This study aimed to assess the prevalence and genomic epidemiology of E. coli BSI isolates in Shanghai, delineate predominant lineages and their related phenotypic and genomic characteristics, and elucidate the population structure. Methods: A total of 136 E. coli strains were collected from a tertiary hospital in Shanghai between 2023 and 2024. We conducted comprehensive analyses, including multilocus sequence typing (MLST), core genome MLST (cgMLST), clonal complex assignment, serotype prediction, identification of antimicrobial resistance genes (ARGs) and plasmid-borne virulence genes, and plasmid mobility prediction. Results: The predominant clonal complex was CC131 (22.8%), followed by CC14 (14%). The highest resistance rate was observed for ampicillin (85.3%), whereas amikacin (3.7%), ertapenem (2.9%), imipenem (2.9%), minocycline (2.2%), and meropenem (2.2%) retained excellent in vitro activity. High resistance to ciprofloxacin (63.2%) and levofloxacin (62.5%) was observed, primarily mediated by mutations in gyrA (S83L, D87N) and parC (S80I), particularly in ST1193 strains. Plasmid-borne siderophore virulence genes co-occurred as gene modules, the majority of which were located on transferable IncFIB plasmids. However, this trend was not uniform across lineages, with the CC131 clones predominantly carrying mobilizable plasmids, while CC14 clones predominantly harbored non-mobilizable plasmids. Conclusions: Our findings reveal the dynamic genetic diversity of E. coli BSI isolates at a tertiary hospital in Shanghai, highlighting the importance of genomic surveillance and providing valuable insights for infection control.

Related

  1. Bloodstream Infections in Patients with Malignancy: Microbiological Epidemiology, Antimicrobial Resistance, and Factors Associated with Mortality in a Nine-Year Single-Center Retrospective Cohort
    Cihan Yeşil, Cemile Arslan Yeşil, Ferhat Yılmaz +2
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. How much is enough? Optimising sampling frames for genomic surveillance of Escherichia coli and Klebsiella spp. bloodstream infections - a retrospective study
    D. Nagy, The NEKSUS Consortium, S. Hopkins +11
    medRxivPreprintCC BY-NCFull textEpidemiology & public healthmedRxiv
  3. Pooled prevalence of third-generation cephalosporin resistance among Escherichia coli bloodstream isolates in Southeast Asia: protocol for systematic review and meta-analysis.
    Jacklyn Hermione Colyson, Kayleen Eleonora Honggoseputro, Aileen F Harianto +3
    BMJ openPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCCrossref
  4. Performance of Direct Identification and EUCAST Rapid Antimicrobial Susceptibility Testing in Bloodstream Infections Using Sepsityper® and Disk Diffusion Methods
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Early best available antibiotic therapy for multidrug-resistant gram-negative bloodstream infections: a target trial emulation
    Luca Mezzadri, Wei Cong Tan, Xinxin Hao +102
    eClinicalMedicinePeer-reviewedCC BY 4.0General medicineCrossref
BibTeX
@article{tulufu2026genomic,
  title = {{Genomic Insight into Escherichia coli Bloodstream Infections at a Tertiary Hospital in Shanghai: Predominance, Genetic Diversity, and Plasmid-Associated Virulence of CC131 and CC14.}},
  author = {Yibadaiti Tulufu and Qiong Wu and Shuzhen Xiao and Yingzhi Wang and Jianqiang Wang and Lizhong Han and Jin Tang},
  journal = {Antibiotics (Basel, Switzerland)},
  year = {2026},
  month = sep,
  doi = {10.3390/antibiotics15100940},
  url = {https://europepmc.org/article/MED/42938681},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Genomic Insight into Escherichia coli Bloodstream Infections at a Tertiary Hospital in Shanghai: Predominance, Genetic Diversity, and Plasmid-Associated Virulence of CC131 and CC14.
AU  - Yibadaiti Tulufu
AU  - Qiong Wu
AU  - Shuzhen Xiao
AU  - Yingzhi Wang
AU  - Jianqiang Wang
AU  - Lizhong Han
AU  - Jin Tang
PY  - 2026
DA  - 2026/09/22
JO  - Antibiotics (Basel, Switzerland)
DO  - 10.3390/antibiotics15100940
UR  - https://europepmc.org/article/MED/42938681
AB  - Background: Bloodstream infection (BSI) caused by Escherichia coli has become a growing clinical threat due to its high incidence and mortality rates. Despite its significant global health burden, the genomic diversity of E. coli in Shanghai has not been systematically investigated, with ramifications for treatment and prevention. This study aimed to assess the prevalence and genomic epidemiology of E. coli BSI isolates in Shanghai, delineate predominant lineages and their related phenotypic and genomic characteristics, and elucidate the population structure. Methods: A total of 136 E. coli strains were collected from a tertiary hospital in Shanghai between 2023 and 2024. We conducted comprehensive analyses, including multilocus sequence typing (MLST), core genome MLST (cgMLST), clonal complex assignment, serotype prediction, identification of antimicrobial resistance genes (ARGs) and plasmid-borne virulence genes, and plasmid mobility prediction. Results: The predominant clonal complex was CC131 (22.8%), followed by CC14 (14%). The highest resistance rate was observed for ampicillin (85.3%), whereas amikacin (3.7%), ertapenem (2.9%), imipenem (2.9%), minocycline (2.2%), and meropenem (2.2%) retained excellent in vitro activity. High resistance to ciprofloxacin (63.2%) and levofloxacin (62.5%) was observed, primarily mediated by mutations in gyrA (S83L, D87N) and parC (S80I), particularly in ST1193 strains. Plasmid-borne siderophore virulence genes co-occurred as gene modules, the majority of which were located on transferable IncFIB plasmids. However, this trend was not uniform across lineages, with the CC131 clones predominantly carrying mobilizable plasmids, while CC14 clones predominantly harbored non-mobilizable plasmids. Conclusions: Our findings reveal the dynamic genetic diversity of E. coli BSI isolates at a tertiary hospital in Shanghai, highlighting the importance of genomic surveillance and providing valuable insights for infection control.
SN  - 2079-6382
ER  -